121 related articles for article (PubMed ID: 11705452)
1. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
Martin V; Sawyer N; Stocco R; Unett D; Lerner MR; Abramovitz M; Funk CD
Biochem Pharmacol; 2001 Nov; 62(9):1193-200. PubMed ID: 11705452
[TBL] [Abstract][Full Text] [Related]
2. The murine cysteinyl leukotriene 2 (CysLT2) receptor. cDNA and genomic cloning, alternative splicing, and in vitro characterization.
Hui Y; Yang G; Galczenski H; Figueroa DJ; Austin CP; Copeland NG; Gilbert DJ; Jenkins NA; Funk CD
J Biol Chem; 2001 Dec; 276(50):47489-95. PubMed ID: 11591709
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human cysteinyl leukotriene 2 receptor.
Heise CE; O'Dowd BF; Figueroa DJ; Sawyer N; Nguyen T; Im DS; Stocco R; Bellefeuille JN; Abramovitz M; Cheng R; Williams DL; Zeng Z; Liu Q; Ma L; Clements MK; Coulombe N; Liu Y; Austin CP; George SR; O'Neill GP; Metters KM; Lynch KR; Evans JF
J Biol Chem; 2000 Sep; 275(39):30531-6. PubMed ID: 10851239
[TBL] [Abstract][Full Text] [Related]
4. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing.
Maekawa A; Kanaoka Y; Lam BK; Austen KF
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2256-61. PubMed ID: 11226226
[TBL] [Abstract][Full Text] [Related]
5. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.
Sarau HM; Ames RS; Chambers J; Ellis C; Elshourbagy N; Foley JJ; Schmidt DB; Muccitelli RM; Jenkins O; Murdock PR; Herrity NC; Halsey W; Sathe G; Muir AI; Nuthulaganti P; Dytko GM; Buckley PT; Wilson S; Bergsma DJ; Hay DW
Mol Pharmacol; 1999 Sep; 56(3):657-63. PubMed ID: 10462554
[TBL] [Abstract][Full Text] [Related]
6. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist.
Nothacker HP; Wang Z; Zhu Y; Reinscheid RK; Lin SH; Civelli O
Mol Pharmacol; 2000 Dec; 58(6):1601-8. PubMed ID: 11093801
[TBL] [Abstract][Full Text] [Related]
8. Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution.
Ogasawara H; Ishii S; Yokomizo T; Kakinuma T; Komine M; Tamaki K; Shimizu T; Izumi T
J Biol Chem; 2002 May; 277(21):18763-8. PubMed ID: 11854273
[TBL] [Abstract][Full Text] [Related]
9. Differential signaling of cysteinyl leukotrienes and a novel cysteinyl leukotriene receptor 2 (CysLT₂) agonist, N-methyl-leukotriene C₄, in calcium reporter and β arrestin assays.
Yan D; Stocco R; Sawyer N; Nesheim ME; Abramovitz M; Funk CD
Mol Pharmacol; 2011 Feb; 79(2):270-8. PubMed ID: 21078884
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the cloned guinea pig leukotriene B4 receptor: comparison to its human orthologue.
Boie Y; Stocco R; Sawyer N; Greig GM; Kargman S; Slipetz DM; O'Neill GP; Shimizu T; Yokomizo T; Metters KM; Abramovitz M
Eur J Pharmacol; 1999 Sep; 380(2-3):203-13. PubMed ID: 10513580
[TBL] [Abstract][Full Text] [Related]
12. An alternative pathway for metabolism of leukotriene D(4): effects on contractions to cysteinyl-leukotrienes in the guinea-pig trachea.
Bäck M; Kumlin M; Cotgreave IA; Dahlén SE
Br J Pharmacol; 2001 Aug; 133(7):1134-44. PubMed ID: 11487525
[TBL] [Abstract][Full Text] [Related]
13. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
14. Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1.
Dupré DJ; Le Gouill C; Gingras D; Rola-Pleszczynski M; Stanková J
J Pharmacol Exp Ther; 2004 Apr; 309(1):102-8. PubMed ID: 14718577
[TBL] [Abstract][Full Text] [Related]
15. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
16. Functional recognition of a distinct receptor preferential for leukotriene E4 in mice lacking the cysteinyl leukotriene 1 and 2 receptors.
Maekawa A; Kanaoka Y; Xing W; Austen KF
Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16695-700. PubMed ID: 18931305
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene D4 induces brain edema and enhances CysLT2 receptor-mediated aquaporin 4 expression.
Wang ML; Huang XJ; Fang SH; Yuan YM; Zhang WP; Lu YB; Ding Q; Wei EQ
Biochem Biophys Res Commun; 2006 Nov; 350(2):399-404. PubMed ID: 17010308
[TBL] [Abstract][Full Text] [Related]
18. Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus.
Chang BS; Chang JC; Wang YS; Huang SC
Neurogastroenterol Motil; 2008 Oct; 20(10):1140-6. PubMed ID: 18651869
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of the first potent and selective antagonist at the cysteinyl leukotriene 2 (CysLT(2)) receptor.
Wunder F; Tinel H; Kast R; Geerts A; Becker EM; Kolkhof P; Hütter J; Ergüden J; Härter M
Br J Pharmacol; 2010 May; 160(2):399-409. PubMed ID: 20423349
[TBL] [Abstract][Full Text] [Related]
20. Differential signaling defects associated with the M201V polymorphism in the cysteinyl leukotriene type 2 receptor.
Brochu-Bourque A; Véronneau S; Rola-Pleszczynski M; Stankova J
J Pharmacol Exp Ther; 2011 Feb; 336(2):431-9. PubMed ID: 20966037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
